JAK Inhibitors Show Promise for Alopecia, Eczema, Vitiligo

A researcher at the forefront shares promising results from small studies. Clinical trials are in progress and he predicts FDA approval for a JAK inhibitor for alopecia and eczema within 3 years.
Medscape Medical News

http://ift.tt/2nbJYTS